Ryan Allway April 25th, 2022 Exclusive, News, Top Story The North American cannabis industry has struggled over the past couple of years, but fundamentals are improving and valuations are becoming attractive. As North America continues to grapple with excess supply issues, challenging margins and regulations, investors are starting to... Read more
CFN Media Sits Down with Hero’s Blackbox CEO Marc Kasabasic to Discuss the Company’s Unique Technology
April 1, 2022
Robin Lefferts April 1st, 2022 App, Exclusive, News, Top Story Hero Technologies Inc. (OTC: HENC) is focused on building a vertically integrated cannabis operation in Michigan that will expand to become a multi-state operation. The company is currently in the midst of the licensing process in Michigan. In anticipation... Read more
New Player in the Michigan Cannabis Market
Michigan March 14, 2022
Robin Lefferts March 14th, 2022 App, Exclusive, News, Top Story The state of Michigan is one of the hottest legal cannabis markets in the United States. According to Andrew Brisbo, Executive Director of Michigan’s Marijuana Regulatory Agency, the state recently passed the $3 billion dollar mark in total sales... Read more
Ryan Allway March 2nd, 2022 Psychedelics, Top Story OXFORD, Ohio and COCONUT CREEK, Fla., March 2, 2022 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an integrated and intellectual property driven biotechnology company developing novel, bespoke psychoactive medicinal candidates targeting the potential treatment of... Read more
Ryan Allway January 28th, 2022 Psychedelics, Top Story Psychedelics have shown tremendous promise in treating depression, anxiety, post-traumatic stress disorder, and a range of other mental health conditions. In particular, assisted psychotherapy combines psychedelic substances with talk therapy to facilitate breakthroughs and help patients that don’t see relief through... Read more
3 Ways to Invest in Ketamine Clinics
January 6, 2022
Ryan Allway January 6th, 2022 App, Exclusive, Psychedelics, Top Story Researchers believe that psychedelics may revolutionize mental health treatments, but FDA-approved psychedelics remain out of reach—with one exception. Unlike psilocybin or MDMA, ketamine is FDA-approved for anesthesia during medical procedures, opening the door to off-label use as a treatment... Read more
How to Capitalize on Europe’s Exploding CBD Market
CBD December 28, 2021
Ryan Allway December 28th, 2021 App, Exclusive, News, Top Story Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing... Read more
Flora Growth Builds a Pathway to Unlocking Shareholder Value
December 13, 2021
Ryan Allway December 13th, 2021 News, Top Story The global cannabis industry will generate more than $30 billion in sales this year according to BDS Analytics, representing a 41% increase over last year’s numbers. While expanding cannabis legalization has been accompanied by a surge in new companies stepping into ... Read more
Ryan Allway December 10th, 2021 Psychedelics, Top Story Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) set out to build a nationwide network of psychedelic-assisted psychotherapy clinics in 2018. Since then, the company has grown its footprint to ten clinics across six states exceeding 60,650 sq.... Read more
PODA Offers a New Take on Heat-Not-Burn Products
December 8, 2021
Ryan Allway December 8th, 2021 App, Exclusive, News, Top Story Countries worldwide are adopting tobacco harm reduction policies to reduce smoking-related deaths and diseases. While smoking prevention and cessation are the centerpieces of these strategies, scientists believe that public health outcomes among smokers could significantly improve if they switch... Read more
